Vasomotor Symptoms Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis

 

Vasomotor Symptoms Market Overview

According to MRFR analysis, the Global Vasomotor Symptoms Market is expected to register a CAGR of 7.27% from 2020 to 2027 and hold a value of USD 8,189 Million till 2027.

The global Market is driven by several factors, such as rising older female population, rising initiatives by public and private organizations to create awareness regarding vasomotor symptoms management options, increasing product launches, and a number of clinical trials by the prominent players in the market. The increasing menopausal women also contribute heavily to the growth of this market. By 2030, the world population of menopausal and postmenopausal women is projected to increase to 1.2 billion, with 47 million new entrants each year.

A lot of market players are dominating the global Vasomotor Symptoms Market. The prominent players are involved in strategic agreements, product launches, and joint ventures to sustain their market positions. For instance, in October 2018, TherapeuticsMD (US) received FDA approval for its first bioidentical hormone therapy BIJUVA, a combination of estradiol and progesterone for moderate to severe vasomotor symptoms associated with menopause.

Market Segmentation

Global Vasomotor Symptoms Market has been segmented based on the Therapy Type and Distribution Channel.

The market, based on therapy type, has been segmented into hormonal and non-hormonal. The market, based on hormonal therapy, has been further divided into estrogen, progesterone, and combination. The market, based on hormonal therapy, held a major share in 2019 owing to the widespread use and high preference rate. The market, based on non-hormonal therapy, has been further divided into antidepressants and others.

The global vasomotor symptoms market has been segmented, based on distribution channel, into hospital pharmacies, online stores, and retail pharmacies. The hospital pharmacies segment held the majority share of the market in 2019 owing to the increasing number of in-visit patient admissions, whereas the online stores segment is projected to be the fastest-growing segment during the study period owing to the increasing preference of this distribution channels owing to the widespread availability and rise in awareness regarding the e-commerce channels.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in 2019, owing to the rise in menopausal women in the US. For instance, in the US, approximately 1.3 million women become menopausal each year. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The European market for vasomotor symptoms is expected to hold a substantial share owing to the increase in the number of clinical trials by the prominent players. The vasomotor symptoms market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in this region is anticipated to be the fastest-growing during the forecast period due to the increasing uptake and adoption rate of hormonal therapy. Increasing patient pool also fuels the market growth. The market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

global vasomotor symptoms market Players are Allergan (Ireland), Pfizer Inc. (US), Eli Lily and Company (US), Novartis AG (Switzerland), Emcure Pharmaceuticals Ltd (India), Merck & Co., Inc. (US), TherapeuticsMD, Inc. (US), Mithra Pharmaceuticals (Belgium), Novo Nordisk A/S (Denmark), Procter & Gamble (US), EndoCeutics, Inc. (Canada), Amag Pharmaceuticals (US), and Teva Pharmaceuticals (Israel).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 


Comments

Post a Comment

Popular posts from this blog

Medical Device Reprocessing Market Development Strategy, Future Plans, Competitive Landscape And Regional Forecast To 2030

Image
  Medical Device Reprocessing Market Overview The global medical device reprocessing market is expected to exhibit a strong 15.7% CAGR over the forecast period from 2022 to 2030, according to the latest research report from Market Research Future (MRFR). The report presents a detailed overview of the global medical device reprocessing market, including an overview of the market’s historical progress and projections about the market’s future growth over the forecast period from 2022 to 2030. The competitive landscape of the market is also assessed in detail in the report, including company profiles of the leading players operating in the market and an analysis of the competitive strategies employed by the major players in the market. The segmentation of the market is also profiled in the report to provide an analysis of the major parts of the market. Readers are given clear indications as to the most profitable areas of the market over the forecast period. Medical device reproce...
Read more

Medical Document Management Systems Market Key Players, Competitive Landscape, Growth, Statistics, Revenue and Industry Analysis Report by 2030

Image
  Medical Document Management Systems Market Overview Medical document management systems have become a necessity due to the vast amounts of patient data which is being generated on a regular basis. Market Research Future has analyzed the global medical document management system market with great scrutiny, and the findings published in its report suggest considerable growth during the upcoming forecast period. The medical document management systems market is expected to reach USD 2.8 billion by 2030 at 10.8% CAGR during the forecast period 2022-2030 A primary driver of the global Medical Document Management Systems Market is the tremendous daily volume of information generated by medical end-users. Medical document management systems offer consolidation of all data in one place for easy data retrieval. Ongoing treatments and patient history can be easily accessed via the use of medical document management systems, thus driving growth for the market. Updation of files in...
Read more

Nanobody Market Forecast Size, Share, Growth, Latest Trends, Global Forecast 2030

Image
  Nanobody Market Overview According to MRFR analysis, the global nanobody market is expected to register a CAGR of 24.2% from 2022 to 2030 and hold a value of over USD 1.14 billion by 2030. The global market of nanobody is driven by various factors, such as rising healthcare expenditure and increasing investments in R&D activities to develop nanobody-based therapeutics. In addition, the growing usage of nanobodies in various applications such as in vivo imaging, antivenom therapy, and immune-based therapeutics among others is also driving the market growth of the nanobody. Moreover, the progress of various nanobody products in clinical trials and their subsequent approval further boost the growth of the market. Furthermore, rising health-related concerns coupled with favorable reimbursement policies for availing healthcare services are anticipated to fuel the growth of the nanobody market during the forecast period. Nanobody Market Segmentation The global nanobod...
Read more